Advertisement

Search Results for "Istaroxime"

10:25 EDT 24th May 2013 | BioPortfolio

Original Source: Istaroxime: Is the Remedy Better than the Disease? : Editorial to: "Chronic Istaroxine Improves Cardiac Function and Heart Rate Variability in Cardiomyopathic Hamsters" by Pietro Lo Giudice et al.

Matching Channels

None

Matching News

None

Matching PubMed Articles

Chronic Istaroxime Improves Cardiac Function and Heart Rate Variability in Cardiomyopathic Hamsters.

PURPOSE: Istaroxime is a new luso-inotropic compound. It exerts inotropic action by reducing Na(+)/K(+)-ATPase activity, and simultaneously it stimulates sarcoplasmic reticulum Ca(2+)-ATPase function,...

Istaroxime: Is the Remedy Better than the Disease? : Editorial to: "Chronic Istaroxine Improves Cardiac Function and Heart Rate Variability in Cardiomyopathic Hamsters" by Pietro Lo Giudice et al.

Acute Heart Failure With Low Cardiac Output: Can We Develop a Short-term Inotropic Agent That Does Not Increase Adverse Events?

Acute heart failure represents an increasingly common cause of hospitalization, and may require the use of inotropic drugs in patients with low cardiac output and evidence of organ hypoperfusion. Howe...

Inotropes in cardiac patients: update 2011.

PURPOSE OF REVIEW: ICU patients frequently develop low output syndromes due to cardiac dysfunction, myocardial injury, and inflammatory activation. Conventional inotropic agents seem to be useful in r...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement